Stocks
Intelligent OutlookMRK-
Intelligent Outlook
MRK-
Prev Close-
50D MA-
200D MA-
52W High-
Live Price
MRK 24H Rolling
0.000.00%0.00
Rolling: Last 24h | 5m
MRK
Asset Information
Company Profile
Company:MRK
Sector:Pharmaceuticals
Industry:Pharmaceuticals
Country:US
Employees:75,000
IPO Date:1949-04-20
Website:www.merck.com/
Technicals & Growth
Market Cap:$206.04B
Shares O/S:2,497,783,211
52W High:$105.07
52W Low:$73.31
50D MA:$84.63
200D MA:$84.51
Financial Ratios
P/E Ratio:10.91
EPS:$7.56
Profit Margin:26.68%
ROE (TTM):36.95%
ROA (TTM):14.63%
Div. Per Share:$3.24
MRK
Merck makes pharmaceutical products to treat several conditions in a number of therapeutic areas, including cardiometabolic disease, cancer, and infections. Within cancer, the firm's immuno-oncology platform, led by Keytruda, is a major contributor to overall sales. The company also has a substantial vaccine business aimed at preventing pediatric diseases, as well as Gardasil for human papillomavirus. Additionally, Merck sells animal health-related drugs. From a geographical perspective, 47% of the company's sales are generated from US human health (pharmaceuticals and vaccines).
Loading chart library...
Financial Data (Macrotrends)
Historical Data
Loading...